Navigation Links
Micropuncture Introducer Sets

ProductsMicropuncture Introducer Sets
Company Cook Incorporated
Item Micropuncture Introducer Sets
Features After initial access and placement of the .018 inch (0.46 mm) diameter Torq-Flex wire guide, the coaxial catheter pair is introduced. Removal of the inner catheter and wire guide facilitates placement of the .035 inch or .038 inch diameter wire guide through the outer catheter. Supplied sterile in peel-open packages. Intended for one-time use.
Description Used for placement of .035 inch (0.89 mm) or .038 inch (0.97 mm) diameter wire guides into the vascular system when a small 21 gage needle stick is desired.
Info Cook Incorporated
Customer Service: (800) 457-4500
Web site: http://www.cookgroup.com/

Related medicine products :

1. Micropuncture Push-Plus Introducer Sets
2. CHECK-FLO Performer Introducer Sets Micropuncture Access
3. Carter Sphere Introducer and Holder
4. Sphere Introducer
5. Fast-Cath & Maximum Hemostasis Introducers
6. Ultimum Introducers
7. Fast-Cath Hemostasis Introducers
8. Maximum Hemostasis Introducers
9. Mullins Introducer Sheaths/Brockenbrough Needles
10. Fast-Cath Guiding Introducers
11. Convoy Catheter Introducer Sheaths
Troponin I EIA Hypertension/ Cardiac Evaluation 025-BC-1105
IGF-BP3 EIA Endocrine Function 022-IGF-E03 Insulin Growth Factor binding protein
Human Growth Hormone EIA Endocrine Function 025-BC-1033
...e enzyme immunoassay. It is based on the direct s...es are directed against separate antigenic determi...ation, insulin in the sample reacts with peroxidas...lin antibodies bound to the microplate wells. A s...
Medicine Products:
(Date:8/8/2008)...gnosis, less successful surgery, pair of studies f... -- The standard screening test for prostate cance...more vulnerable to the disease, and surgery is les...tudies found. , "Obese men are more likely to b...," said Dr. Stephen Freedland, an associate profes...
(Date:8/8/2008)...A, Md., Aug. 8 /PRNewswire-FirstCall/ -- Hanger Or...nnounce that Moody,s Investors,Service revised its...itive",from "stable." Moody,s also affirmed Hanger...re pleased with the outlook change from Moody,s as...ten quarters," remarked George McHenry,Hanger,s C...
(Date:8/7/2008)...ls of testosterone may be a key factor in spreadin... findings could help explain why males in a popula...ansmit disease., , Previous research has linked...tem suppression. Studies have shown that males, co...e, and account for a larger share of disease trans...
(Date:8/7/2008)...urgh Tissue Engineering Initiative Marks 12th Year...p, PITTSBURGH, Aug. 7 /PRNewswire/ -- Twenty-four...ties, primarily across southwestern Pennsylvania,a...2th annual Summer,Internship Program of the Pittsb...l of the program is to expose greatly increased nu...
Breaking Medicine News(10 mins):Health News:Obese Men Face Twin Threat From Prostate Cancer 2Health News:Testosterone key to disease transmission 2Health News:Thirty-seven College Students Participate in Regenerative Medicine Summer Research Program 2Health News:Thirty-seven College Students Participate in Regenerative Medicine Summer Research Program 3
...nticipation of a fearful situation can play an imp... the University of Wisconsin-Madison, while conduc...f memory have come up with the findings that the v...l situation can stir up two memory-forming regions...
...atients taking newer blood pressure drugs have a d... an analysis of the biggest clinical trial in Euro...eople on newer medicines developed diabetes as aga...ugs. The study involved 19,000 people. The study ...
... study in the September issue of Archives of Pedia...ves journals says that hospitals must be prepared ...f and equipment to treat injured and noninjured ch...he report is based on the experience of training a...
...olgate-Palmolive (India) Limited, the market leade...tal Association (IDA) today announced that Septemb... in its third year, Oral Health Month (OHM) is an ...gn in India to establish and promote the importanc...
Other Medicine News:Health News:Anticipation Could Have An Intense Effect On Memory 2Health News:Anticipation Could Have An Intense Effect On Memory 3Health News:Military Hospitals Need To Be Prepared To Treat Children 2Health News:Striving to Make India Free from Tooth Decay 2
(Date:8/5/2008)...BRIDGE, Mass., Aug. 5 /- Tolerx, Inc....very and development of novel,therapies for the tr...ay,that Genentech, a collaborator, has moved a mod...clonal antibody, into a phase 1 clinical trial,tha... is evaluating the,safety and tolerability of both...
(Date:8/5/2008)...Clinical study planned for advanced or recurrent s...FirstCall/ -- Medarex, Inc.,(Nasdaq: MEDX ) annou... drug,application (IND) filed with the U.S. Food &...reatment of patients with selected advanced or rec...noma, melanoma, non-small cell,lung cancer or epit...
(Date:8/5/2008)...-Term Clinical Study Confirms Effectiveness of Aut...RNewswire/ -- The results of a two-year,representa...e,internationally renowned journal "Osteoarthritis...ess of Orthokine therapy, in which,anti-inflammato...are,injected into the arthritic joint., Researche...
(Date:8/5/2008)...MOUTH JUNCTION, N.J., Aug. 5 /- Micro... that the first clinical milestone in its,collabor...liate, has been,achieved, triggering the first pay...ose,s dry powder inhaler (DPI) technology announce...tion by Merck of a Phase I clinical,study of an in...
Breaking Medicine Technology:Tolerx Announces Achievement of Milestones upon anti-CD4 Antibody Program Advancement and Initiation of Phase 1 Clinical Trial 2Tolerx Announces Achievement of Milestones upon anti-CD4 Antibody Program Advancement and Initiation of Phase 1 Clinical Trial 3Medarex Announces Allowance of Investigational New Drug Application for Wholly-Owned Fully Human Anti-PD-L1 Antibody, MDX-1105 2Medarex Announces Allowance of Investigational New Drug Application for Wholly-Owned Fully Human Anti-PD-L1 Antibody, MDX-1105 3Orthokine Treatment is Effective for Knee Arthritis, Even After Two Years 2MicroDose Technologies Announces Achievement of Phase I Clinical Milestone Triggering First Milestone Payment Under Collaboration with Merck & Co., Inc. 2BioSpace and the Massachusetts Biotechnology Council Launch 2008 Genetown 28TM 29 Hotbed Campaign 2545 1BioSpace and the Massachusetts Biotechnology Council Launch 2008 Genetown 28TM 29 Hotbed Campaign 2545 2Transgenes Therapeutic Vaccine TG4010 Shows Promising Preliminary Phase IIb Data in Advanced Non Small Cell Lung Cancer 2541 1Transgenes Therapeutic Vaccine TG4010 Shows Promising Preliminary Phase IIb Data in Advanced Non Small Cell Lung Cancer 2541 2Transgenes Therapeutic Vaccine TG4010 Shows Promising Preliminary Phase IIb Data in Advanced Non Small Cell Lung Cancer 2541 3Biofuels Sustainability 1842 1Biofuels Sustainability 1842 2Biofuels Sustainability 1842 3Protein in human hair shows promise for regenerating nerves 9372 1Protein in human hair shows promise for regenerating nerves 9372 2Protein in human hair shows promise for regenerating nerves 9372 3
...sponse and Remission in,Follow-up to Phase 1 and P...atients with IV Steroid-Refractory Ulcerative Coli...stCall/ -- Data,presented at the Digestive Disease...y Dr. William Sandborn from the Mayo Clinic,sugges...pment as a,treatment for intravenous steroid-refra...
...007 - BioLineRx Ltd.,(TASE:BLRX), Israel,s leading...m its Phase I trial of BL-1020, the first GABA,enh...atment of,schizophrenia. The trial demonstrated th...d biochemical evidence of dopamine,blockade which ...,data in a poster (Abstract 235 XX) at the 2007 Am...
Other Medicine Technology:PDL BioPharma Announces Long-Term Nuvion Data Presented at 2007,Digestive Disease Week 2PDL BioPharma Announces Long-Term Nuvion Data Presented at 2007,Digestive Disease Week 3PDL BioPharma Announces Long-Term Nuvion Data Presented at 2007,Digestive Disease Week 4PDL BioPharma Announces Long-Term Nuvion Data Presented at 2007,Digestive Disease Week 5BioLineRx Presents Data From Successful Phase I Trial for BL-1020,in Schizophrenia at American Psychiatric Association Conference 2BioLineRx Presents Data From Successful Phase I Trial for BL-1020,in Schizophrenia at American Psychiatric Association Conference 3BioLineRx Presents Data From Successful Phase I Trial for BL-1020,in Schizophrenia at American Psychiatric Association Conference 4